Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xi'an
Clinical trial register · China

Clinical Trials in Xi'an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Xi'an 41 Lanzhou 3 Ankang 2 Shijiazhuang 2 Changsha 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xijing Hospital123 Tang-Du Hospital50 First Affiliated Hospital Xi'an Jiaotong University41 Xijing Hospital of Digestive Diseases19 Air Force Military Medical University, China17 Clear sponsor filter
Site location
Xi'an41 Lanzhou3 Ankang2 Shijiazhuang2 Changsha1
All 20 locations
Target enrolment
to

Trials with a site in Xi'an

41 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
MRI-Based Neurodevelopmental Risk Stratification in Infants With White Matter Injury
NCT07860749Punctate White Matter Lesions, Neurodevelopmental Outcomes, Preterm Infants
First Affiliated Hospital Xi'an Jiaotong University
Observational
260
Xi'an, Ankang, Chengdu, Hangzhou, Lanzhou, Qinghai, Shanghai, Shijiazhuang
2026-10
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Phase 3
820
Lanzhou, Shijiazhuang, Zhengzhou, Loudi, Dalian, Xining, Xi'an, Taiyuan
2026-04-07
Not yet open
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
NCT07168291Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma ( FL), Burkitt Lymphoma
First Affiliated Hospital Xi'an Jiaotong University
Early Phase 1
3
Xi'an
2025-12-31
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Phase 2
24
Xi'an
2025-10-30
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,150
Xi'an
2025-08-10
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Phase 3
224
Xi'an
2025-06-01
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
290
Xi'an
2025-05-13
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2025-04-01
By invitation
First Affiliated Hospital Xi'an Jiaotong University
Early Phase 1
150
Xi'an
2025-01-15
Not yet open
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
NCT05694273Arrhythmia, Acute Cerebrovascular Disease
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2025-01-15
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
42
Xi'an
2025-01-10
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2025-01-01
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
5,000
Xi'an
2024-12-31
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-12-31
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
4,000
Xi'an
2024-12-30
Recruiting
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NCT06684106Hyperlipidemia, Ursodeoxycholic Acid, Statin Therapy, Glucose Intolerance
DrugUDCA
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
128
Xi'an
2024-11-25
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-10-30
Recruiting
Intravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease
NCT06567938Coronary Artery Disease, Chronic Kidney Diseases
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,528
Xi'an
2024-07-25
Not yet open
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
44
Xi'an
2024-07-15
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
80
Xi'an
2024-06-27
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-05-09
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-05-09
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2024-04-09
Recruiting
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
NCT06199401Type A Aortic Dissection, Complication of Surgical Procedure, Aortic Diseases
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
680
Xi'an
2024-01-11
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
80
Xi'an
2024-01-06
Recruiting
Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting
NCT06141525Coronary Artery Bypass Grafting, Remote Ischemic Conditioning, Ischemia-Reperfusion Injury
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
648
Xi'an
2023-11-22
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
100
Xi'an
2023-10-30
Recruiting
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
NCT06125847Homozygous Familial Hypercholesterolemia
First Affiliated Hospital Xi'an Jiaotong University
Early Phase 1
21
Xi'an
2023-10-29
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
40
Xi'an
2023-10-26
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-08-25
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-04-23
Not yet open
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
NCT05681403Lymphoma, Autologous Hematopoietic Stem Cell Transplantation
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
53
Xi'an
2023-01-15
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an, Ankang, Changsha, Hanzhong, Jinan, Lanzhou, Weinan, Xianyang
2023-01-06
Recruiting
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
40
Xi'an
2023-01-05
Recruiting
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
NCT06001073Coronary Artery Disease, Arrhythmias, Cardiac, Heart Valve Diseases, Aortic Dissection
First Affiliated Hospital Xi'an Jiaotong University
Observational
25,000
Xi'an
2022-12-05
Active, closed
To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse
NCT07730619Plaque Psoriasis, Biologic Agents, Relapse, Influence Factors
First Affiliated Hospital Xi'an Jiaotong University
Observational
140
Xi'an
2022-12-01
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2022-11-10
Not yet open
Neoadjuvant PDT in the Treatment of Cholangiocarcinoma
NCT04824742Cholangiocarcinoma Resectable
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
50
Xi'an
2021-04-01
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
205
Xi'an
2018-06-01
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
200
Xi'an
2017-06-15
Active, closed
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2016-07-01
Rows per page Showing 1–41 of 41
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 41 of those studies with a site in Xi'an that also match the filters currently applied.

How many clinical trials are recruiting in Xi'an?

26 of the 41 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 12 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xi'an), 41 studies
PhaseStudiesRecruitingShare
Observational211351.2%
Not applicable12829.3%
Early Phase 1317.3%
Phase 3224.9%
Phase 4214.9%
Phase 2112.4%

Most active sponsors

Lead sponsors with the most studies (Xi'an)
Lead sponsorStudiesRecruiting
First Affiliated Hospital Xi'an Jiaotong University4126
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.